Stay updated on CTI-1601 in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the CTI-1601 in Friedreich's Ataxia Clinical Trial page.

Latest updates to the CTI-1601 in Friedreich's Ataxia Clinical Trial page
- CheckyesterdayChange DetectedThe record now presents details of a completed Phase 1 CTI-1601-versus-placebo study for Friedreich’s ataxia, including eligibility criteria, study design, outcomes, investigators, and record dates.SummaryDifference49%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check22 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the study page remained an error page.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the usual study details. This indicates access to the record is blocked, preventing viewing of the trial information.SummaryDifference18%

Stay in the know with updates to CTI-1601 in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTI-1601 in Friedreich's Ataxia Clinical Trial page.